PI3K pathway analysis is also expected to be of value to assess the functional activity status of a variety of immune cell types (e.g., lymphocyte subpopulations) in the anti-cancer immune response, which may be of help to predict response to immunotherapy [64,67]. This evidence concerns the gene PIK3CB and cancer.